Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | BUB1 | O43683 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL421810 | 0.82 | CTSL (0.49) | LMNACTSLCTSBCTSKTSHR | |
| SCHEMBL10000009 | 0.80 | GLA (0.47) | LMNANPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL4392777 | 0.78 | TAAR1 (0.48) | LMNACTSLCTSBCTSKTAAR1 | |
| SCHEMBL17019782 | 0.78 | TSHR (0.58) | LMNACTSLCTSBCTSKTAAR1 | |
| SCHEMBL1928095 | 0.78 | TSHR (0.58) | LMNACTSLCTSBCTSKTAAR1 | |
| SCHEMBL15060580 | 0.78 | MEN1 (0.38) | NPC1ALDH1A1HPGDNFKB1MAOB | |
| SCHEMBL664313 | 0.77 | SIGMAR1 (0.45) | CTSLCTSBCTSKNPC1ALDH1A1 | |
| SCHEMBL4869082 | 0.76 | CTSL (0.47) | LMNACTSLCTSBCTSKAKT1 | |
| SCHEMBL4869078 | 0.76 | CTSL (0.47) | LMNACTSLCTSBCTSKAKT1 | |
| SCHEMBL19239030 | 0.75 | SLC18A3 (0.43) | TAAR1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-11180608-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-11180608-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-11149114-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-10-19 | — | — | US | disclosed |
| US-10980234-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10779539-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC. (US) | 2020-09-22 | — | — | US | disclosed |
| CN-107257813-B | Block copolymers having surface active anchoring groups, compositions and methods thereof | AZ电子材料卢森堡有限公司 | 2020-08-21 | — | — | CN | disclosed |
| EP-3259292-B1 | BLOCK COPOLYMERS WITH SURFACE-ACTIVE JUNCTION GROUPS, COMPOSITIONS AND PROCESSES THEREOF | AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) | 2020-04-08 | — | — | EP | disclosed |
| US-10610597-B2 | Polycarbonates bearing aromatic N-heterocycles for drug delivery | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-04-07 | — | — | US | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110150977-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110150977-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305300-A1 | Method of Ring-Opening Polymerization, and Related Compositions and Articles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305300-A1 | Method of Ring-Opening Polymerization, and Related Compositions and Articles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11149114-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | DCLRE1A, ODC1, MRTO4 | LMNA 1106/4885CTSL 3229/4885CTSB 2431/4885 |
| US-11180608-B2 | Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto | DCLRE1A, ODC1, MRTO4 | LMNA 1106/4885CTSL 3229/4885CTSB 2431/4885 |
| US-10980234-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | LMNA 4337/4885CTSL 1974/4885CTSB 2418/4885 |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | LMNA 4337/4885CTSL 1974/4885CTSB 2418/4885 |
| US-20110150977-A1 | ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF | MLEC, NOD2, PAM | LMNA 1300/4885CTSL 3272/4885CTSB 2484/4885 |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | PFAS, PAM, PCNA | LMNA 1875/4885CTSL 3374/4885CTSB 4040/4885 |
| US-10779539-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | LMNA 4337/4885CTSL 1974/4885CTSB 2418/4885 |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | SAMM50, ADRM1, UFM1 | LMNA 2738/4885CTSL 1944/4885CTSB 1698/4885 |
| US-10610597-B2 | Polycarbonates bearing aromatic N-heterocycles for drug delivery | PAH, SULT1E1, SULT1A1 | LMNA 3428/4885CTSL 4542/4885CTSB 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.